Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Repurposing of Kinase Inhibitors for Treatment of COVID-19

Pharmaceutical Research(2020)10.1007/s11095-020-02851-7Source: DataRank Database

Repurposing of Kinase Inhibitors for Treatment of COVID-19 is a research paper published in Pharmaceutical Research (2020). On theSindex it has a DataRank of 0. It has been cited 153 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access153 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 11.56)OA: bronzeTopics (37)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Alexander Parent ORCID,Priscilla L. Yang ORCID,Martin Sattler ORCID,Qingsong Liu ORCID,Qingwang Liu ORCID

Live enrichment

PubMed:32778962 PMC:PMC7417114 OpenAlex:https://openalex.org/W3048782484

National Institutes of Health

Grant: Project Program Grant, NIH PO1CA66996

NCI NIH HHS

Grant: P01 CA066996

FWCI

11.56

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: https://www.springer.com/tdm

journalhttps://link.springer.com/content/pdf/10.1007/s11095-020-02851-7.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s11095-020-02851-7.pdf

publisherhttps://link.springer.com/article/10.1007/s11095-020-02851-7/fulltext.html

journalhttps://doi.org/10.1007/s11095-020-02851-7

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32778962

Fields of Study

Quinazolinone synthesis and applicationsPARP inhibition in cancer therapyCalcium signaling and nucleotide metabolism

MeSH Terms

COVID-19AnimalsAntiviral AgentsHumansPneumonia, ViralCoronavirus InfectionsProtein Kinase InhibitorsDrug RepositioningPandemics

Keywords

Drug repositioningRepurposingPharmacologyMedicineDrugKinasePharmacokineticsDrug discoveryViral life cycleClinical trialPotencyVirusViral replicationImmunologyBioinformaticsBiologyInternal medicineIn vitroSARS-CovCoronavirusAntiviral TherapyKinase InhibitorsMers-covCovid-19Sars-cov-2

Repurposing of Kinase Inhibitors for Treatment of COVID-19

FAIR Checklist

Authors (11)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)